All In Biotech

Free tool

FAERS Monitor: Ilaris

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125319 or its brand name (Ilaris, Canakinumab). Reports on generic versions are filed under their own applications.

Reports

10,910

Serious

5,167

47% of reports

Hospitalization

2,449

Death reported

489

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pyrexia1,442
  • drug ineffective1,242
  • inappropriate schedule of drug administration1,242
  • inappropriate schedule of product administration966
  • pain946
  • condition aggravated876
  • off label use751
  • malaise731
  • arthralgia613
  • rash571
  • incorrect dose administered506
  • joint swelling492
  • headache445
  • fatigue400
  • pulmonary embolism391

Reports by year received

View as table
YearReports
20091
20109
201161
2012188
201398
2014143
2015493
2016956
20171,421
20181,130
2019985
20201,206
2021734
20221,021
2023972
2024632
2025521
2026339

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,249 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
inappropriate schedule of drug administrationSignal1,24234.232.539,477
inappropriate schedule of product administrationSignal96610.49.88,209
pyrexiaSignal1,4428.17.79,027
pulmonary embolismSignal3918.07.22,374
joint swellingSignal4927.97.22,956
condition aggravatedSignal8765.65.23,317
incorrect dose administeredSignal5064.33.91,280
malaiseSignal7313.23.01,136
painSignal9463.02.81,271
arthralgiaSignal6132.82.6745
rashSignal5712.52.3536
drug ineffective1,2421.81.7486
off label use7511.71.5202
headache4451.41.245
fatigue4001.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.